BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 36240850)

  • 1. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Azad N; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Jeck W; Johung KL; Kirilcuk N; Krishnamurthi S; Maratt JK; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stotsky-Himelfarb E; Tavakkoli A; Willett CG; Gregory K; Gurski L
    J Natl Compr Canc Netw; 2022 Oct; 20(10):1139-1167. PubMed ID: 36240850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Gurski L; Freedman-Cass DA
    J Natl Compr Canc Netw; 2018 Jul; 16(7):874-901. PubMed ID: 30006429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Farkas L; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Johung KL; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Gurski LA
    J Natl Compr Canc Netw; 2021 Mar; 19(3):329-359. PubMed ID: 33724754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal Cancer, Version 2.2015.
    Benson AB; Venook AP; Bekaii-Saab T; Chan E; Chen YJ; Cooper HS; Engstrom PF; Enzinger PC; Fenton MJ; Fuchs CS; Grem JL; Grothey A; Hochster HS; Hunt S; Kamel A; Kirilcuk N; Leong LA; Lin E; Messersmith WA; Mulcahy MF; Murphy JD; Nurkin S; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Freedman-Cass D
    J Natl Compr Canc Netw; 2015 Jun; 13(6):719-28; quiz 728. PubMed ID: 26085388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.
    Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Gunn A; Hoffe S; Hubbard J; Hunt S; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Johnson-Chilla A; Gurski LA
    J Natl Compr Canc Netw; 2020 Jul; 18(7):806-815. PubMed ID: 32634771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease.
    Kolarich A; George TJ; Hughes SJ; Delitto D; Allegra CJ; Hall WA; Chang GJ; Tan SA; Shaw CM; Iqbal A
    Cancer; 2018 Sep; 124(17):3510-3519. PubMed ID: 29984547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
    Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Chang S; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Guzzo T; Herr HW; Hoffman-Censits J; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Michalski J; Montgomery JS; Nandagopal L; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wright JL; Gurski LA; Johnson-Chilla A
    J Natl Compr Canc Netw; 2020 Mar; 18(3):329-354. PubMed ID: 32135513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fuchs CS; Grem JL; Hunt S; Leong LA; Lin E; Martin MG; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Freedman-Cass DA; Gregory KM
    J Natl Compr Canc Netw; 2012 Dec; 10(12):1528-64. PubMed ID: 23221790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Locoregional Rectal Cancer.
    Willett CG
    J Natl Compr Canc Netw; 2018 May; 16(5S):617-619. PubMed ID: 29784739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.
    Reyngold M; Niland J; ter Veer A; Milne D; Bekaii-Saab T; Cohen SJ; Lai L; Schrag D; Skibber JM; Small W; Weiser M; Wilkinson N; Goodman KA
    J Natl Compr Canc Netw; 2014 Feb; 12(2):235-43. PubMed ID: 24586085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonoperative management of rectal cancer: identifying the ideal patients.
    Habr-Gama A; São Julião GP; Perez RO
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):135-51. PubMed ID: 25475576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonoperative Management of Rectal Cancer: The Watch and Wait Strategy.
    Vailati BB; São Julião GP; Habr-Gama A; Perez RO
    Surg Oncol Clin N Am; 2022 Apr; 31(2):171-182. PubMed ID: 35351272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
    Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
    Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA;
    J Natl Compr Canc Netw; 2013 May; 11(5):519-28. PubMed ID: 23667203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 18. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.
    Crawford A; Firtell J; Caycedo-Marulanda A
    J Gastrointest Cancer; 2019 Jun; 50(2):260-268. PubMed ID: 29388060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus on the Watch and Wait policy in rectal cancer patients after neoadjuvant treatment (2020 version)].
    ; ; ; ;
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):1-9. PubMed ID: 31958923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.